 |
|
| Blog results | Results 1 - 10 of about 21,999 for treatment for female sexual dysfunction. (0.28 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Female Sexuality Medical Center in New York (NY) - Sexual Disorders - http://www.centerforfemalesexuality.com/ | |
| 8 Mar 2009 by Dr Petra Female Sexual Dysfunction is a controversial problem. While undoubtedly many women do have problems with their sex lives; the cause(s), prevalence and treatment(s) of women's sexual problems are hotly debated. ... Dr Petra Boynton - http://www.drpetra.co.uk/blog/ - References [ More results from Dr Petra Boynton ] |
| 20 Nov 2009 by SaferDates With women likelier to report sexual problems than men, sales for the U.S. market alone are projected to surpass the $2 billion Americans spend on erectile dysfunction treatments. Before the money starts rolling in, however, ... SaferDates Blog - http://saferdates.com/blog/ - References |
| 17 Nov 2009 BioSante Pharmaceuticals Comments on Boehringer Ingelheim Clinical Test Results in Treatment of Female Sexual Dysfunction. LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nov 16, 2009 - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html |
| 16 Nov 2009 by Business Wire LINCOLNSHIRE, Ill.--(BUSINESS WIRE)-- BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), a specialty pharmaceutical company developing products for female sexual health, including Libi. Your Story - http://www.your-story.org/ [ More results from Your Story ] |
| 13 Nov 2009 by pillscribe Flibanserin, whose phase 3 data will be presented this week at a meeting on sexual disorders in Lyon, is being watched as female Viagra with the potential to revolutionize the treatment of the rather complex medical condition of ... DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/ - References [ More results from DWS Pill Scribe ] |
| 15 Nov 2009 "Despite studies demonstrating that HSDD is a common form of female sexual dysfunction, there is currently no approved prescription treatment for pre-menopausal women suffering from the condition" said Professor Rossella Nappi, ... Boehringer Ingelheim RSS-Newsfeed - http://www.boehringer-ingelheim.com/ [ More results from Boehringer Ingelheim RSS-Newsfeed ] |
| 17 Nov 2009 by Rick Nauert PhD The trials measured mean changes from baseline on the following six variables as reported by the women each week: number of satisfying sexual events (SSE), electronic diary (eDiary) desire score, female sexual function index (FSFI) ... The researchers concluded that treatment with 100 milligrams of flibanserin once a day was associated with significant improvements versus placebo in the number of satisfying sexual events (SSE) reported, sexual desire (as measured by ... Psych Central News - http://psychcentral.com/news/ - References |
| 27 Oct 2009 Anorgasmia is typically classified or specified in one of three ways; as primary, secondary, or situational. Primary anorgasmia means that the analyzed woman. Orgasm Hypnosis - http://orgasmhypnosis.net/ |
| 20 Oct 2009 This recommendation by the DMC, after their confidential review of unblinded data, to continue the study without changes, is a validation of the safety to date of LibiGel in the treatment of female sexual dysfunction (FSD) in menopausal ... Latest articles from PMD - http://www.pmdcentral.com/ [ More results from Latest articles from PMD ] |
| 18 Nov 2009 by Sarah Eileen Tonn It's called flibanserin and there is no telling if it will be approved for treatment of female sexual dysfunction in Canada or the US. The Time article also stated that some physicians believe sexual dysfunction in women is a myth. ... MagMe - http://www.magme.com/blog/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
